{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T02:12:26Z","timestamp":1790993546809,"version":"4.1.0"},"reference-count":93,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2024,10,12]],"date-time":"2024-10-12T00:00:00Z","timestamp":1728691200000},"content-version":"vor","delay-in-days":299,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Vitiligo is a common chronic autoimmune disorder characterized by skin and hair depigmentation that affects 0.5%\u20132.0% of the global population. Vitiligo is associated with diminished quality of life (QoL) and psychosocial burden. The burden of vitiligo may vary based on skin tone and cultural differences as well as geographical variations in disease awareness, societal stigma, healthcare systems and treatment options. Data on the burden and management of vitiligo in Africa, the Middle East and Latin America are scarce. Literature searches using terms covering vitiligo in Africa, the Middle East and Latin America were conducted using PubMed to identify relevant publications that focused on disease prevalence and burden, QoL and psychosocial impact and disease management between 2011 and 2021. Most of the reviewed studies were conducted in the Middle East, and most Latin American studies were from Brazil. Most studies involved small patient numbers and may not be generalizable. Reported prevalence of vitiligo ranged from 0.18% to 5.3% in Africa and the Middle East, and from 0.04% to 0.57% in Latin America. In several studies, prevalence was higher among female participants. Generally, non-segmental vitiligo was the dominant clinical variant identified and the age at onset varied widely across studies. Common comorbidities include autoimmune diseases such as Hashimoto's thyroiditis, alopecia areata and diabetes. Few treatment guidelines exist in these regions, with the exceptions of guidelines published by the Brazilian and Argentinian Societies of Dermatology. There is a clear unmet need for large epidemiological studies with uniform methodology to accurately ascertain the true prevalence of vitiligo in Africa, the Middle East and Latin America. Additional data on vitiligo burden and management in Africa and Latin America are also needed, along with local disease management guidelines that consider genetic variation, psychosocial burden and socioeconomic diversity in all 3 regions.<\/jats:p>","DOI":"10.1002\/ski2.317","type":"journal-article","created":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T05:14:45Z","timestamp":1702962885000},"source":"Crossref","is-referenced-by-count":17,"title":["Prevalence and Burden of Vitiligo in Africa, the Middle East and Latin America"],"prefix":"10.1093","volume":"4","author":[{"given":"Anwar","family":"Al Hammadi","sequence":"first","affiliation":[{"name":"Dermamed Clinic , Dubai ,","place":["United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caio Cesar","family":"Silva de Castro","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Pontif\u00edcia Universidade Cat\u00f3lica do Paran\u00e1 , Curitiba ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9732-9993","authenticated-orcid":false,"given":"Nisha V.","family":"Parmar","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Rashid Hospital , Dubai ,","place":["United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Ubogui","sequence":"additional","affiliation":[{"name":"Psoriahue Medicina Interdisciplinaria , Buenos Aires ,","place":["Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nael","family":"Hatatah","sequence":"additional","affiliation":[{"name":"King Salman Hospital , Riyadh ,","place":["Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2883-3317","authenticated-orcid":false,"given":"Haytham Mohamed","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Pfizer , Dubai ,","place":["United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyndon","family":"Llamado","sequence":"additional","affiliation":[{"name":"Pfizer , Makati ,","place":["Philippines"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,12,18]]},"reference":[{"issue":"6","key":"2025112510515231500_ski2317-bib-0001","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1159\/000506103","article-title":"Vitiligo: a review","volume":"236","author":"Bergqvist","year":"2020","journal-title":"Dermatology"},{"issue":"3","key":"2025112510515231500_ski2317-bib-0002","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1111\/j.1755-148x.2012.00997.x","article-title":"Revised classification\/nomenclature of vitiligo and related issues: the vitiligo global issues consensus conference","volume":"25","author":"Ezzedine","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"issue":"2","key":"2025112510515231500_ski2317-bib-0003","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.det.2016.11.005","article-title":"Segmental vitiligo","volume":"35","author":"van Geel","year":"2017","journal-title":"Dermatol Clin"},{"issue":"10","key":"2025112510515231500_ski2317-bib-0004","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1111\/j.1365-4632.2011.05377.x","article-title":"A review of the worldwide prevalence of vitiligo in children\/adolescents and adults","volume":"51","author":"Kruger","year":"2012","journal-title":"Int J Dermatol"},{"issue":"9","key":"2025112510515231500_ski2317-bib-0005","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0163806","article-title":"The prevalence of vitiligo: a meta-analysis","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS One"},{"issue":"6","key":"2025112510515231500_ski2317-bib-0006","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s40257-021-00631-6","article-title":"Psychosocial effects of vitiligo: a systematic literature review","volume":"22","author":"Ezzedine","year":"2021","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"2025112510515231500_ski2317-bib-0007","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2022.2164171","article-title":"The landscape of vitiligo in Latin America: a call to action","volume":"34","author":"Londo\u00f1o-Garcia","year":"2023","journal-title":"J Dermatol Treat"},{"key":"2025112510515231500_ski2317-bib-0008","doi-asserted-by":"publisher","DOI":"10.1016\/j.lana.2023.100524","article-title":"How persistent stigma and discrimination keep people with visible skin diseases out of jobs: vitiligo in Brazil today","volume":"23","author":"Silveira","year":"2023","journal-title":"Lancet Reg Health Am"},{"issue":"6","key":"2025112510515231500_ski2317-bib-0009","doi-asserted-by":"publisher","first-page":"682","DOI":"10.15537\/smj.2021.42.6.20200833","article-title":"Quality of life in vitiligo patients in central Saudi Arabia","volume":"42","author":"Al-Shammari","year":"2021","journal-title":"Saudi Med J"},{"issue":"1","key":"2025112510515231500_ski2317-bib-0010","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/ijd.13366","article-title":"Vitiligo on black skin: epidemiological and clinical aspects in dermatology, Cotonou (Benin)","volume":"56","author":"Degboe","year":"2017","journal-title":"Int J Dermatol"},{"issue":"3","key":"2025112510515231500_ski2317-bib-0011","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1111\/jocd.14192","article-title":"Prevalence of hypopigmentary disorders in primary school children in Zagazig City, Sharkia Governorate, Egypt","volume":"21","author":"Khater","year":"2022","journal-title":"J Cosmet Dermatol"},{"issue":"10","key":"2025112510515231500_ski2317-bib-0012","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1111\/j.1365-4632.2012.05475.x","article-title":"Epidemiologic study of dermatologic disorders among children in South Sinai, Egypt","volume":"51","author":"Yamamah","year":"2012","journal-title":"Int J Dermatol"},{"key":"2025112510515231500_ski2317-bib-0013","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1111\/ijd.12148","article-title":"Prevalence of vitiligo among type 2 diabetic patients in an Iranian population","volume":"53","author":"Afkhami-Ardekani","year":"2014","journal-title":"Int J Dermatol"},{"issue":"1","key":"2025112510515231500_ski2317-bib-0014","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/j.1525-1470.2011.01478.x","article-title":"Vitiligo in children: a clinical-epidemiologic study in Jordan","volume":"29","author":"Al-Refu","year":"2012","journal-title":"Pediatr Dermatol"},{"issue":"7","key":"2025112510515231500_ski2317-bib-0015","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1111\/jdv.12216","article-title":"Quantification and comparison of psychiatric distress in African patients with albinism and vitiligo: a 5-year prospective study","volume":"28","author":"Ajose","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2025112510515231500_ski2317-bib-0016","first-page":"556","article-title":"Pattern of presentation of patients with vitiligo in a tertiary hospital in southern Nigeria: a five year retrospective study","volume":"38","author":"Madubuko","year":"2021","journal-title":"W Afr J Med"},{"issue":"2","key":"2025112510515231500_ski2317-bib-0017","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1179\/2046905515y.0000000012","article-title":"Pattern of paediatric dermatoses at dermatology clinics in Ile-Ife and Ilesha, Nigeria","volume":"36","author":"Oninla","year":"2016","journal-title":"Paediatr Int Child Health"},{"key":"2025112510515231500_ski2317-bib-0018","first-page":"1291","article-title":"Vitiligo-epidemiological study of 4134 patients at the National Center for Vitiligo and Psoriasis in central Saudi Arabia","volume":"32","author":"Alissa","year":"2011","journal-title":"Saudi Med J"},{"key":"2025112510515231500_ski2317-bib-0019","first-page":"1175","article-title":"Prevalence of skin disorders and associated socio-economic factors among primary school children in the eastern region of Saudi Arabia","volume":"69","author":"Rahamathulla","year":"2019","journal-title":"J Pakistan Med Assoc"},{"key":"2025112510515231500_ski2317-bib-0020","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.ijwd.2019.07.002","article-title":"Prevalence of pigmentary disorders: a cross-sectional study in public hospitals in Durban, South Africa","volume":"5","author":"Dlova","year":"2019","journal-title":"Int J Womens Dermatol"},{"issue":"2","key":"2025112510515231500_ski2317-bib-0021","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1365-4632.2012.05600.x","article-title":"Quality of life of patients with vitiligo attending the regional dermatology training center in northern Tanzania","volume":"52","author":"Kiprono","year":"2013","journal-title":"Int J Dermatol"},{"key":"2025112510515231500_ski2317-bib-0022","first-page":"278","article-title":"Clinical epidemiological profile of vitiligo","volume":"89","author":"Kiprono","year":"2012","journal-title":"East Afr Med J"},{"issue":"1","key":"2025112510515231500_ski2317-bib-0023","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-016-1933-6","article-title":"Skin diseases among elderly patients attending skin clinic at the Regional Dermatology Training Centre, Northern Tanzania: a cross-sectional study","volume":"9","author":"Mponda","year":"2016","journal-title":"BMC Res Notes"},{"issue":"2","key":"2025112510515231500_ski2317-bib-0024","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/j.1346-8138.2011.01377.x","article-title":"Profile of vitiligo patients attending a training and research hospital in central Anatolia: a retrospective study","volume":"39","author":"Gonul","year":"2012","journal-title":"J Dermatol"},{"issue":"6","key":"2025112510515231500_ski2317-bib-0025","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1590\/abd1806-4841.20165060","article-title":"Knowledge, beliefs, and perceptions of Turkish vitiligo patients regarding their condition","volume":"91","author":"Topal","year":"2016","journal-title":"An Bras Dermatol"},{"key":"2025112510515231500_ski2317-bib-0026","first-page":"124","article-title":"Evaluation of the clinical and sociodemographic features of Turkish patients with vitiligo","volume":"24","author":"Oguz Topal","year":"2016","journal-title":"Acta Dermatovenerol Croat"},{"key":"2025112510515231500_ski2317-bib-0027","first-page":"397","article-title":"Classification and comparative study of vitiligo in southeast of Turkey with biochemical and immunological parameters","volume":"164","author":"Kalkanli","year":"2013","journal-title":"Clin Ter"},{"issue":"7","key":"2025112510515231500_ski2317-bib-0028","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1111\/ijd.12055","article-title":"A study of clinical profiles of vitiligo in different ages: an analysis of 669 outpatients","volume":"53","author":"de Barros","year":"2014","journal-title":"Int J Dermatol"},{"issue":"3","key":"2025112510515231500_ski2317-bib-0029","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1111\/pcmr.12681","article-title":"Prevalence of vitiligo in Brazil\u2014a population survey","volume":"31","author":"de Cesar Silva Castro","year":"2018","journal-title":"Pigment Cell Melanoma Res"},{"issue":"6","key":"2025112510515231500_ski2317-bib-0030","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1590\/abd1806-4841.20132219","article-title":"Clinical epidemiological profile of vitiligo in children and adolescents","volume":"88","author":"Marinho Fde","year":"2013","journal-title":"An Bras Dermatol"},{"issue":"2","key":"2025112510515231500_ski2317-bib-0031","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/ijd.14645","article-title":"Clinical and epidemiological characteristics of childhood vitiligo: a study of 701 patients from Brazil","volume":"59","author":"Martins","year":"2020","journal-title":"Int J Dermatol"},{"issue":"4","key":"2025112510515231500_ski2317-bib-0032","doi-asserted-by":"publisher","first-page":"243","DOI":"10.2991\/jegh.k.190920.001","article-title":"Population-based study of 24 autoimmune diseases carried out in a Brazilian microregion","volume":"9","author":"Tolentino Junior","year":"2019","journal-title":"J Epidemiol Glob Health"},{"issue":"7","key":"2025112510515231500_ski2317-bib-0033","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.adengl.2017.06.001","article-title":"Impact of vitiligo on quality of life","volume":"108","author":"Morales-S\u00e1nchez","year":"2017","journal-title":"Actas Dermosifiliogr"},{"issue":"1","key":"2025112510515231500_ski2317-bib-0034","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jdermsci.2011.09.011","article-title":"A pattern of association between clinical form of vitiligo and disease-related variables in a Brazilian population","volume":"65","author":"de Silva Castro","year":"2012","journal-title":"J Dermatol Sci"},{"issue":"1","key":"2025112510515231500_ski2317-bib-0035","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/pde.12714","article-title":"Focus on the top ten diagnoses could reduce pediatric dermatology referrals","volume":"33","author":"Kakande","year":"2016","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"2025112510515231500_ski2317-bib-0036","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/jocd.13451","article-title":"Childhood vitiligo in Egypt: clinico-epidemiologic profile of 483 patients","volume":"20","author":"El-Husseiny","year":"2021","journal-title":"J Cosmet Dermatol"},{"issue":"3","key":"2025112510515231500_ski2317-bib-0037","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1111\/ijd.13425","article-title":"Effects of age of onset on disease characteristics in non-segmental vitiligo","volume":"56","author":"Solak","year":"2017","journal-title":"Int J Dermatol"},{"issue":"12","key":"2025112510515231500_ski2317-bib-0038","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0240221","article-title":"Tumor necrosis factor (TNF)-\u03b1- 308 G\/A gene polymorphism (rs1800629) in Egyptian patients with alopecia areata and vitiligo, a laboratory and in silico analysis","volume":"15","author":"Abd El-Raheem","year":"2020","journal-title":"PLoS One"},{"issue":"3","key":"2025112510515231500_ski2317-bib-0039","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.4238\/2013.july.8.1","article-title":"Tumor necrosis factor-\u03b1 and -\u03b2 genetic polymorphisms as a risk factor in Saudi patients with vitiligo","volume":"12","author":"Al-Harthi","year":"2013","journal-title":"Genet Mol Res"},{"key":"2025112510515231500_ski2317-bib-0040","doi-asserted-by":"crossref","first-page":"366","DOI":"10.4103\/ijd.IJD_300_20","article-title":"The study of serum level of interleukin-2, interleukin-6, and tumor necrosis factor-alpha in stable and progressive vitiligo patients from Sina Hospital in Tabriz, Iran","volume":"66","author":"Ranjkesh","year":"2021","journal-title":"Indian J Dermatol"},{"key":"2025112510515231500_ski2317-bib-0041","doi-asserted-by":"publisher","first-page":"825","DOI":"10.2147\/ccid.s272970","article-title":"Effect of TNF-\u03b1 -308G\/A (rs1800629) promoter polymorphism on the serum level of TNF-\u03b1 among Iraqi patients with generalized vitiligo","volume":"13","author":"Ahmed","year":"2020","journal-title":"Clin Cosmet Invest Dermatol"},{"issue":"5","key":"2025112510515231500_ski2317-bib-0042","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1089\/gtmb.2014.0326","article-title":"Association of angiotensin-converting enzyme ACE gene polymorphism with ACE activity and susceptibility to vitiligo in Egyptian population","volume":"19","author":"Badran","year":"2015","journal-title":"Genet Test Mol Biomarkers"},{"key":"2025112510515231500_ski2317-bib-0043","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/exd.12810","article-title":"Genetic and biochemical evidence implicates the butyrylcholinesterase gene BCHE in vitiligo pathogenesis","volume":"24","author":"do Machado Nascimento","year":"2015","journal-title":"Exp Dermatol"},{"issue":"6","key":"2025112510515231500_ski2317-bib-0044","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/exd.14100","article-title":"Association study between vitiligo and autoimmune-related genes CYP27B1, REL, TNFAIP3, IL2 and IL21","volume":"29","author":"Martins","year":"2020","journal-title":"Exp Dermatol"},{"issue":"7","key":"2025112510515231500_ski2317-bib-0045","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1038\/jid.2010.34","article-title":"Genetic variants of the DDR1 gene are associated with vitiligo in two independent Brazilian population samples","volume":"130","author":"de Silva Castro","year":"2010","journal-title":"J Invest Dermatol"},{"issue":"4","key":"2025112510515231500_ski2317-bib-0046","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/exd.12641","article-title":"Polymorphism of the E-cadherin gene CDH1 is associated with susceptibility to vitiligo","volume":"24","author":"Tarle","year":"2015","journal-title":"Exp Dermatol"},{"issue":"8","key":"2025112510515231500_ski2317-bib-0047","doi-asserted-by":"publisher","first-page":"4478","DOI":"10.1016\/j.sjbs.2021.04.045","article-title":"Deleterious effect of angiotensin-converting enzyme gene polymorphism in vitiligo patients","volume":"28","author":"Basher","year":"2021","journal-title":"Saudi J Biol Sci"},{"key":"2025112510515231500_ski2317-bib-0048","doi-asserted-by":"publisher","first-page":"260732","DOI":"10.1155\/2014\/260732","article-title":"Transporter TAP1-637G and immunoproteasome PSMB9-60H variants influence the risk of developing vitiligo in the Saudi population","volume":"2014","author":"Elhawary","year":"2014","journal-title":"Dis Markers"},{"issue":"10","key":"2025112510515231500_ski2317-bib-0049","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.1416","article-title":"Macrophage inhibitory factor (MIF) gene polymorphisms are associated with disease susceptibility and with circulating MIF levels in active non-segmental vitiligo in patients from western Mexico","volume":"8","author":"Garcia-Orozco","year":"2020","journal-title":"Mol Genet Genomic Med"},{"key":"2025112510515231500_ski2317-bib-0050","first-page":"359","article-title":"Study of human leukocyte antigen-cw in Egyptian patients with vitiligo","volume":"14","author":"Hassab El Naby","year":"2015","journal-title":"J Drugs Dermatol JDD"},{"key":"2025112510515231500_ski2317-bib-0051","first-page":"745","article-title":"Prospective cross-sectional study of quality of life of vitiligo patients using a vitiligo specific quality of life instrument","volume":"37","author":"Anaba","year":"2020","journal-title":"W Afr J Med"},{"issue":"5","key":"2025112510515231500_ski2317-bib-0052","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1684\/ejd.2013.2139","article-title":"Impact of vitiligo on the health-related quality of life of 104 adult patients, using Dermatology Life Quality Index and stress score: first Egyptian report","volume":"23","author":"Fawzy","year":"2013","journal-title":"Eur J Dermatol"},{"issue":"5","key":"2025112510515231500_ski2317-bib-0053","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1159\/000448656","article-title":"Quality of life impairment in children and adults with vitiligo: a cross-sectional study based on dermatology-specific and disease-specific quality of life instruments","volume":"232","author":"Catucci Boza","year":"2016","journal-title":"Dermatology"},{"issue":"6","key":"2025112510515231500_ski2317-bib-0054","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1590\/s0365-05962011000600008","article-title":"Impact on the quality of life of dermatological patients in southern Brazil","volume":"86","author":"Tejada Cdos","year":"2011","journal-title":"An Bras Dermatol"},{"issue":"1","key":"2025112510515231500_ski2317-bib-0055","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12955-016-0490-y","article-title":"Quality of life in patients with vitiligo: a cross-sectional study based on Vitiligo Quality of Life index (VitiQoL)","volume":"14","author":"Hedayat","year":"2016","journal-title":"Health Qual Life Outcome"},{"key":"2025112510515231500_ski2317-bib-0056","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1590\/abd1806-4841.20165744","article-title":"Vitiligo-specific instrument on quality of life\u2014Brazilian Portuguese version","volume":"91","author":"Boza","year":"2016","journal-title":"An Bras Dermatol"},{"issue":"3","key":"2025112510515231500_ski2317-bib-0057","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1590\/abd1806-4841.20153684","article-title":"Translation, cross-cultural adaptation and validation of the vitiligo-specific health-related quality of life instrument (VitiQoL) into Brazilian Portuguese","volume":"90","author":"Boza","year":"2015","journal-title":"An Bras Dermatol"},{"issue":"3","key":"2025112510515231500_ski2317-bib-0058","doi-asserted-by":"publisher","first-page":"169","DOI":"10.4103\/npmj.npmj_579_21","article-title":"Quality of life impairment amongst persons living with vitiligo using disease specific vitiligo quality of life index: a Nigerian perspective","volume":"28","author":"Abdullahi","year":"2021","journal-title":"Niger Postgrad Med J"},{"issue":"11","key":"2025112510515231500_ski2317-bib-0059","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.15537\/smj.2021.42.11.20210560","article-title":"Quality of life assessment among patients suffering from different dermatological diseases","volume":"42","author":"AlOtaibi","year":"2021","journal-title":"Saudi Med J"},{"issue":"2","key":"2025112510515231500_ski2317-bib-0060","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s12529-017-9677-9","article-title":"Validation of an Egyptian Arabic version of Skindex-16 and quality of life measurement in Egyptian patients with skin disease","volume":"25","author":"Essa","year":"2018","journal-title":"Int J Behav Med"},{"issue":"1","key":"2025112510515231500_ski2317-bib-0061","doi-asserted-by":"publisher","first-page":"33","DOI":"10.4103\/0974-2077.79188","article-title":"Quality of life in Saudi vitiligo patients","volume":"4","author":"Al-Mubarak","year":"2011","journal-title":"J Cutan Aesthetic Surg"},{"issue":"6","key":"2025112510515231500_ski2317-bib-0062","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s40257-013-0037-5","article-title":"Quality of life in family members of vitiligo patients: a questionnaire study in Saudi Arabia","volume":"14","author":"Bin Saif","year":"2013","journal-title":"Am J Clin Dermatol"},{"key":"2025112510515231500_ski2317-bib-0063","doi-asserted-by":"publisher","first-page":"383","DOI":"10.2147\/ccid.s151114","article-title":"Vitiligo and social acceptance","volume":"11","author":"Bidaki","year":"2018","journal-title":"Clin Cosmet Invest Dermatol"},{"issue":"1","key":"2025112510515231500_ski2317-bib-0064","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12955-020-1278-7","article-title":"Evaluating prevalence of depression, anxiety and hopelessness in patients with vitiligo on an Iranian population","volume":"18","author":"Hamidizadeh","year":"2020","journal-title":"Health Qual Life Outcome"},{"issue":"2","key":"2025112510515231500_ski2317-bib-0065","doi-asserted-by":"publisher","first-page":"108","DOI":"10.5455\/msm.2020.32.108-111","article-title":"Identifying patients at higher risk of depression among patients with vitiligo at outpatient setting","volume":"32","author":"Alharbi","year":"2020","journal-title":"Mater Sociomed"},{"issue":"3","key":"2025112510515231500_ski2317-bib-0066","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s40257-016-0172-x","article-title":"Social anxiety and quality of life in vitiligo and acne patients with facial involvement: a cross-sectional controlled study","volume":"17","author":"Salman","year":"2016","journal-title":"Am J Clin Dermatol"},{"issue":"2","key":"2025112510515231500_ski2317-bib-0067","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1590\/s0365-05962011000200006","article-title":"Vitiligo epidemiological profile and the association with thyroid disease","volume":"86","author":"Nunes","year":"2011","journal-title":"An Bras Dermatol"},{"issue":"12","key":"2025112510515231500_ski2317-bib-0068","doi-asserted-by":"publisher","first-page":"570","DOI":"10.3923\/pjbs.2013.570.574","article-title":"Frequency of autoimmune diseases in those suffering from vitiligo in comparison with normal population","volume":"16","author":"Nejad","year":"2013","journal-title":"Pakistan J Biol Sci"},{"key":"2025112510515231500_ski2317-bib-0069","doi-asserted-by":"crossref","first-page":"232","DOI":"10.5114\/ada.2016.60617","article-title":"Thyroid abnormalities in paediatric patients with vitiligo: retrospective study","volume":"33","author":"Kartal","year":"2016","journal-title":"Postepy Dermatol Alergol"},{"key":"2025112510515231500_ski2317-bib-0070","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/435947","article-title":"The frequency of autoimmune thyroid disease in alopecia areata and vitiligo patients","volume":"2015","author":"Saylam Kurtipek","year":"2015","journal-title":"BioMed Res Int"},{"issue":"7","key":"2025112510515231500_ski2317-bib-0071","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1111\/ijd.14381","article-title":"Alopecia areata in Tunisia: epidemio-clinical aspects and comorbid conditions. A prospective study of 204 cases","volume":"58","author":"Arousse","year":"2019","journal-title":"Int J Dermatol"},{"issue":"2","key":"2025112510515231500_ski2317-bib-0072","doi-asserted-by":"publisher","first-page":"140","DOI":"10.2310\/7750.2014.14074","article-title":"Evaluation between association of psoriasis and vitiligo","volume":"19","author":"Yazdanpanah","year":"2015","journal-title":"J Cutan Med Surg"},{"key":"2025112510515231500_ski2317-bib-0073","doi-asserted-by":"publisher","first-page":"425","DOI":"10.2147\/ccid.s257022","article-title":"Vitiligo and rise in blood pressure\u2014a case-control study in a referral dermatology clinic in southern Iran","volume":"13","author":"Namazi","year":"2020","journal-title":"Clin Cosmet Invest Dermatol"},{"issue":"Suppl 1","key":"2025112510515231500_ski2317-bib-0074","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.abd.2020.05.007","article-title":"Consensus on the treatment of vitiligo\u2014Brazilian Society of Dermatology","volume":"95","author":"Dellatorre","year":"2020","journal-title":"An Bras Dermatol"},{"issue":"1","key":"2025112510515231500_ski2317-bib-0075","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/phpp.12593","article-title":"Efficacy of combination therapy of narrowband-ultraviolet B phototherapy or excimer laser with topical tacrolimus for vitiligo: an updated systematic review and meta-analysis","volume":"37","author":"Chang","year":"2021","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"2025112510515231500_ski2317-bib-0076","author":"US Food and Drug Administration","journal-title":"FDA approves topical treatment addressing repigmentation in vitiligo in patients aged 12 and older"},{"issue":"3","key":"2025112510515231500_ski2317-bib-0077","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3109\/09546634.2012.762638","article-title":"Vitiligo management strategy in Jeddah, Saudi Arabia as reported by dermatologists and experienced by patients","volume":"25","author":"Ismail","year":"2014","journal-title":"J Dermatol Treat"},{"key":"2025112510515231500_ski2317-bib-0078","author":"Sociedad Argentina de Dermatologia","journal-title":"Consenso sobre vitiligo"},{"issue":"2","key":"2025112510515231500_ski2317-bib-0079","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.abd.2019.02.014","article-title":"Noncultured epidermal cell suspension for the treatment of recalcitrant segmental vitiligo in a solid-organ transplant recipient","volume":"95","author":"Dellatorre","year":"2020","journal-title":"An Bras Dermatol"},{"issue":"2","key":"2025112510515231500_ski2317-bib-0080","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1590\/s0365-05962013000200004","article-title":"Prevalence study of dermatoses referred to the phototherapy unit at the dermatology service of the Clinics Hospital of Porto Alegre, RS, Brazil","volume":"88","author":"Casara","year":"2013","journal-title":"An Bras Dermatol"},{"issue":"1","key":"2025112510515231500_ski2317-bib-0081","doi-asserted-by":"publisher","first-page":"74","DOI":"10.4103\/0378-6323.90950","article-title":"Survey of dermatologists' phototherapy practices for vitiligo","volume":"78","author":"Alghamdi","year":"2012","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"2","key":"2025112510515231500_ski2317-bib-0082","doi-asserted-by":"publisher","first-page":"115","DOI":"10.5144\/0256-4947.2014.115","article-title":"Correlation of clinical efficacy and psychosocial impact on vitiligo patients by excimer laser treatment","volume":"34","author":"Al-Shobaili","year":"2014","journal-title":"Ann Saudi Med"},{"issue":"6","key":"2025112510515231500_ski2317-bib-0083","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1590\/abd1806-4841.20176332","article-title":"Optimizing suction blister epidermal graft technique in the surgical treatment of vitiligo","volume":"92","author":"Dellatorre","year":"2017","journal-title":"An Bras Dermatol"},{"key":"2025112510515231500_ski2317-bib-0084","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1111\/jdv.15411","article-title":"Six-year follow-up of vitiligo patients successfully treated with autologous non-cultured melanocyte-keratinocyte transplantation","volume":"33","author":"Altalhab","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"2025112510515231500_ski2317-bib-0085","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1111\/jdv.12674","article-title":"The additive effect of excimer laser on non-cultured melanocyte-keratinocyte transplantation for the treatment of vitiligo: a clinical trial in an Iranian population","volume":"29","author":"Ebadi","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2025112510515231500_ski2317-bib-0086","first-page":"e74","article-title":"Melanocytes transplantation in patients with vitiligo using needling micrografting technique","volume":"12","author":"Sharquie","year":"2013","journal-title":"J Drugs Dermatol JDD"},{"issue":"10","key":"2025112510515231500_ski2317-bib-0087","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1111\/j.1468-3083.2010.03946.x","article-title":"Non-cultured melanocyte-keratinocyte transplantation for the treatment of vitiligo: a clinical trial in an Iranian population","volume":"25","author":"Toossi","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"2025112510515231500_ski2317-bib-0088","doi-asserted-by":"publisher","first-page":"33","DOI":"10.12816\/0006069","article-title":"Prevailing misconceptions of vitiligo among Saudi school children","volume":"8","author":"Sharaf","year":"2014","journal-title":"Int J Health Sci"},{"issue":"6","key":"2025112510515231500_ski2317-bib-0089","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14009","article-title":"Psychodermatology in Iran: a survey on knowledge, awareness, and practice patterns in Iranian dermatologists","volume":"33","author":"Handjani","year":"2020","journal-title":"Dermatol Ther"},{"key":"2025112510515231500_ski2317-bib-0090","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.2147\/ppa.s230921","article-title":"Treatment adherence among patients with five dermatological diseases and four treatment types\u2014a cross-sectional study","volume":"13","author":"Alsubeeh","year":"2019","journal-title":"Patient Prefer Adherence"},{"issue":"6","key":"2025112510515231500_ski2317-bib-0091","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/dth.12397","article-title":"Treatment adherence and beliefs about medicines among Egyptian vitiligo patients","volume":"29","author":"Ali","year":"2016","journal-title":"Dermatol Ther"},{"issue":"3","key":"2025112510515231500_ski2317-bib-0092","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/pcmr.12354","article-title":"Developing core outcome set for vitiligo clinical trials: international e-Delphi consensus","volume":"28","author":"Eleftheriadou","year":"2015","journal-title":"Pigment Cell Melanoma Res"},{"issue":"5","key":"2025112510515231500_ski2317-bib-0093","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1111\/pcmr.12784","article-title":"Validation of a physician global assessment tool for vitiligo extent: results of an international vitiligo expert meeting","volume":"32","author":"van Geel","year":"2019","journal-title":"Pigment Cell Melanoma Res"}],"container-title":["Skin Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/skinhd\/article-pdf\/4\/1\/ski2.317\/59729994\/skinhd_4_1_e317.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/skinhd\/article-pdf\/4\/1\/ski2.317\/59729994\/skinhd_4_1_e317.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T15:52:04Z","timestamp":1764085924000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/skinhd\/article\/doi\/10.1002\/ski2.317\/7755694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,18]]},"references-count":93,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12,18]]},"published-print":{"date-parts":[[2024,2,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ski2.317","relation":{},"ISSN":["2690-442X"],"issn-type":[{"value":"2690-442X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,2]]},"published":{"date-parts":[[2023,12,18]]},"article-number":"ski2.317"}}